Advances in the Prevention of Cardiovascular Diseases by Phytosterol
Author: 
Ningzhu BaiAuthors Info & Claims
Ningzhu BaiAuthors Info & ClaimsPages 110 - 114
Abstract
Cardiovascular diseases, mainly atherosclerosis and coronary heart disease, are crucial causes for worldwide morbidity and mortality. Unhealthy lifestyle and diet with high low-density lipoprotein (LDL)-cholesterol level are the major risk factors. Preventions of CVDs need to be taken early in age by changing to more phytosterol-enriched diet. Phytosterol is plant-derived compound with similar structure and function as cholesterol, but when supplied with food, it can lower the serum cholesterol concentration. Studies recommend the daily intake of 2g to 2.5g supplement of phytosterol can significantly reduce plasma LDL-cholesterol level. There are many researches on the mechanisms of cholesterol-lowering effect of plant sterol and plant stanol. It has been found that the differences in solubility and hydrophobicity enable phytosterol to intervene cholesterol from incorporating into micelles and to co-precipitate with cholesterol into solid crystals in intestinal lumen and reduce the absorption of cholesterol. Phytosterol also promotes the transporter gene expression to increase the cholesterol excretion back into small intestine. Furthermore, phytosterol also affects cholesterol metabolism and its transport in blood stream. Therefore, food enriched with phytosterol can be an efficient and safe method of preventing CVDs.
References
[1]
Berger, Alvin, Peter JH Jones, and Suhad S. Abumweis. 2004. Plant Sterols: Factors Affecting Their Efficacy and Safety as Functional Food Ingredients. Lipids in health and disease3, 1 (2004), 5.
[2]
Berry, Jarett D., et al. Lifetime Risks of Cardiovascular Disease. New England Journal of Medicine 366, 17 (2012), 1641--1643.
[3]
Fady Y. Ntanios, Peter J.h Jones, and Jiri J. Frohlich. 1998. Dietary Sitostanol Reduces Plaque Formation but not Lecithin Cholesterol Acyl Transferase Activity in Rabbits. Atherosclerosis138, 1 (1998), 101--110.
[4]
Gylling, Helena, et al. 1999. Serum Sterols during Stanol Ester Feeding in a Mildly Hypercholesterolemic Population. Journal of lipid research40, 4 (1999), 593--600.
[5]
Jogchum Plat and Ronald P. Mensink. 2005. Plant Stanol and Sterol Esters in the Control of Blood Cholesterol Levels: Mechanism and Safety Aspects. The American Journal of Cardiology96, 1 (2005), 15--22.
[6]
Jogchum Plat, Jason A. Nichols, and Ronald P. Mensink. 2005. Plant Sterols and Stanols: Effects on Mixed Micellar Composition and LXR (target gene) Activation. Journal of Lipid Research46, 11 (2005), 2468--2476.
[7]
Jogchum Plat and Ronald P. Mensink. 2002. Increased Intestinal ABCA1 Expression Contributes to the Decrease in Cholesterol Absorption after Plant Stanol Consumption. The FASEB journal16, 10 (2002), 1248--1253.
[8]
Jones, Peter J., et al. 2000. Modulation of Plasma Lipid Levels and Cholesterol Kinetics by Phytosterol versus Phytostanol Esters. Journal of Lipid Research41, 5(2000), 697--705.
[9]
Klaus Von Bergmann, Thomas Sudhop, and Dieter Lütjohann. 2005. Cholesterol and Plant Sterol Absorption: Recent Insights. The American Journal of Cardiology96, 1 (2005), 10--14.
[10]
L. Christiansen, M. Karjalainen, T. Seppänen-Laakso, R. Hiltunen, and J. Yliruusi. 2003. Effect of β-sitosterol on Precipitation of Cholesterol from Non-aqueous and Aqueous Solutions. International Journal of Pharmaceutics254, 2 (2003), 155--166.
[11]
Liqing Yu et al.2002. Overexpression of ABCG5 and ABCG8 Promotes Biliary Cholesterol Secretion and Reduces Fractional Absorption of Dietary Cholesterol. Journal of Clinical Investigation110, 5 (2002), 671--680.
[12]
Maarit A. Hallikainen, Essi S. Sarkkinen, and Matti I.J. Uusitupa. 2000. Plant Stanol Esters Affect Serum Cholesterol Concentrations of Hypercholesterolemic Men and Women in a Dose-dependent Manner. The Journal of Nutrition130, 4 (2000), 767--776.
[13]
Markku Nissinen, Helena Gylling, Matti Vuoristo, and Tatu A. Miettinen. 2002. Micellar distribution of cholesterol and phytosterols after duodenal plant stanol ester infusion. American Journal of Physiology-Gastrointestinal and Liver Physiology282, 6 (2002).
[14]
Matthew W. Gillman. 2015. Primordial Prevention of Cardiovascular Disease. Circulation131, 7 (2015), 599--601.
[15]
Yasuhiko Homma, Ikuo Ikeda, Toshitsugu Ishikawa, Masao Tateno, Michihiro Sugano, and Haruo Nakamura. 2003. Decrease in Plasma Low-Density Lipoprotein Cholesterol, Apolipoprotein B, Cholesteryl Ester Transfer Protein, and Oxidized Low-Density Lipoprotein by Plant Stanol Ester-Containing Spread: Nutrition19, 4 (2003), 369--374.
- Advances in the Prevention of Cardiovascular Diseases by Phytosterol
Recommendations
Fuzzy logic system for diabetic eye morbidity prediction
Diabetes is a common chronic disease; the number of people who are affected by this health problem is increasing worldwide, leading to a high cost for healthcare systems. Therefore, the main contribution of this paper is to present a fuzzy logic system ...
Ensemble framework for cardiovascular disease prediction
AbstractHeart disease is the major cause of non-communicable and silent death worldwide. Heart diseases or cardiovascular diseases are classified into four types: coronary heart disease, heart failure, congenital heart disease, and ...
Highlights- The proposed framework consists of Stacking Based Ensemble learning which adds diversity to the classifier.
Effects of Ginkgo Biloba Extract on Cellular Cholesterol Content and CD36 Expression of Macrophages from Diabetic Rats
ICBEB '12: Proceedings of the 2012 International Conference on Biomedical Engineering and BiotechnologyWe did the experiment for exploring effects of Ginkgo leaf extract (EGb) on levels of cellular cholesterol content and CD36 expression of macrophages from diabetic rats, and to investigate the possible action-mechanism of EGb treatment atherosclerosis ...
Comments
Information & Contributors
Information
Published In
May 2019
207 pages
ISBN:9781450371995
DOI:10.1145/3340037
Copyright © 2019 ACM.
Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than ACM must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected]
In-Cooperation
- University of Electronic Science and Technology of China: University of Electronic Science and Technology of China
Publisher
Association for Computing Machinery
New York, NY, United States
Publication History
Published: 17 May 2019
Check for updates
Author Tags
Qualifiers
- Research-article
- Research
- Refereed limited
Conference
ICMHI 2019
ICMHI 2019: The third International Conference on Medical and Health Informatics 2019
May 17 - 19, 2019
Xiamen, China
Contributors
Other Metrics
Bibliometrics & Citations
Bibliometrics
Article Metrics
- 0Total Citations
- 85Total Downloads
- Downloads (Last 12 months)8
- Downloads (Last 6 weeks)0
Reflects downloads up to 05 Mar 2025
Other Metrics
Citations
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Sign in